12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Tuesday's intraday session, several healthcare stocks experienced significant movements. Redhill Biopharma (RDHL) saw a 62.0% increase, Cardio Diagnostics Hldgs (CDIO) rose by 27.87%, and Heart Test Laboratories (HSCS) increased by 24.98%. Conversely, Tharimmune (THAR) dropped by 71.8%, SenesTech (SNES) fell by 45.22%, and Cabaletta Bio (CABA) declined by 34.44%. Other notable movers included SpringWorks Therapeutics (SWTX), Iterum Therapeutics (ITRM), IMAC Hldgs (BACK), Biodexa Pharmaceuticals (BDRX), Gracell Biotechnologies (GRCL), and Autolus Therapeutics (AUTL).
November 28, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cabaletta Bio's shares declined by 34.44% to $12.26, with a market cap of $525.3 million.
The stock's decline is a strong indicator of negative market sentiment, which could persist in the short term.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
SenesTech shares fell sharply by 45.22% to $1.03.
Such a significant decline often reflects negative market sentiment, which could lead to further short-term depreciation in stock value.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Tharimmune shares plummeted by 71.8% to $0.99 during the session.
A drop of this magnitude typically indicates negative investor sentiment or reactions to adverse company news, suggesting potential further short-term downside.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Cardio Diagnostics Hldgs shares increased by 27.87% to $2.89, with a market cap of $54.1 million.
The significant rise in share price could attract more attention to the stock, potentially leading to further short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Heart Test Laboratories' stock rose 24.98% to $0.27, with a market cap of $13.0 million.
The stock's significant increase suggests positive sentiment that could lead to further short-term appreciation.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Redhill Biopharma's stock soared by 62.0% to $1.62, with a market cap of $17.9 million.
The substantial increase in stock price indicates strong investor interest, which could lead to continued short-term upward momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100